Hong Kong's Investment Promotion Plan Welcomes 22 New Strategic Enterprises, Including Cobo and RedotPay

The Hong Kong Office for Introducing Key Enterprises (OASES) announced on the 20th the sixth batch of key enterprises, which includes leading American pharmaceutical company Pfizer, mainland pharmaceutical giant Heng Rui Medicine, chip design firm Haiguang Information, digital asset custody institution Cobo Fintech HK Limited, and stablecoin payment fintech company RedotPay, among others. During the signing ceremony, Financial Secretary Paul Chan noted the diverse backgrounds of these enterprises. Currently, there are 124 key enterprises expected to bring in an investment of HKD 73 billion and create 25,000 new jobs. He mentioned that 75% of these enterprises will establish regional or international headquarters in Hong Kong, 90% will set up research centers, and many companies are interested in settling in the Northern Metropolis area.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin